[Influence of carbenoxolone therapy on the renin-angiotensin-aldosterone system].
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D005260:Female; D006035:Glycyrrhiza; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy; D010946:Plants, Medicinal; D011188:Potassium / Q000097:blood*; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood*; D013386:Succinates / Q000009:adverse effects; D013729:Terpenes / Q000009:adverse effects*
D013386:Succinates; D013729:Terpenes; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D011188:Potassium
Der Einfluss einer Carbenoxolon-Therapie auf das Renin-Angiotensin-Aldosteron-System.